RecruitingNot ApplicableNCT06145724
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
EnCoRe MoMS Aim 1: Develop and Implement a Community-informed Institutional Obstetric Sepsis Bundle
Sponsor
Columbia University
Enrollment
33,183 participants
Start Date
Jun 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Sepsis is the second leading cause of maternal death in the U.S. Labor and postpartum are particularly vulnerable risk periods. The goal of this multi-center, multidisciplinary study is to evaluate a maternal sepsis safety bundle.
Eligibility
Sex: FEMALE
Inclusion Criteria2
- Birthing Person (EMR evaluation):
- Delivery hospitalizations and associated postpartum readmissions at the 4 hospital sites between 2020-2025
Exclusion Criteria2
- Birthing Person (EMR evaluation)
- Delivery hospitalizations (and associated postpartum readmissions)to a hospital other than the 4 hospital sites or outside of 2020-2025 timeframe
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
BEHAVIORALMaternal Sepsis Safety Bundle
Maternal sepsis safety bundle implemented at Columbia, Lincoln, Harlem, and Allen hospitals.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06145724
Related Trials
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
NCT000061501 location
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
NCT058814471 location
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
NCT009677851 location
Collection of Blood Samples for New Diagnostic Devices 2
NCT055689667 locations
Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)
NCT057706224 locations